Ashraf Khan
About
Dr. Ashraf Khan’s clinical interest includes diagnostic surgical pathology of Breast and Endocrine system. Dr. Khan is actively involved in clinical translational research focused in the field of thyroid and breast cancer investigating biomarkers that help in the diagnosis and prediction of outcome in these tumors. Over the past decade Dr. Khan has published several papers on the role of cell cycle regulatory proteins, translation initiation factors and cell adhesion molecules in the diagnosis of thyroid follicular tumors and progression of thyroid cancer. Dr. Khan was a key contributor of one large multi-institution international study published in The Lancet on the role of galectin 3 and CD44 in the diagnosis of thyroid malignancy. Dr. Khan’s collaboration with the basic scientists in the department of cancer biology at UMass has resulted in multiple projects includingb4-integrin signature in basal-like breast cancer which was recently published and Sox-9 expression in breast cancer which is work in progress. In addition Dr. Khan is a PI on a Department of Defense Grant in collaboration with Dr. Leslie Shaw in department of cancer biology looking at the Insulin Receptor Substrate Proteins (IRS1 and IRS2) in breast cancer with special focus on potential role they may play in Herceptin resistance in HER-2 positive breast cancer. He is also currently involved in studying the micro RNA signature in breast cancer especially estrogen receptor positive node negative tumors with potential therapeutic implications. Dr. Khan is a member of the UMASS graduate school of biomedical sciences representing cancer biology.
Dr. Khan is the past President and Secretary of the Endocrine Pathology Society, a companion society of the US and Canadian Academy of Pathology. He is a reviewer for a number of pathology and endocrinology journals, serves on the editorial board of the journal Endocrine Pathology and is the Section Editor (Endocrine Pathology) of the Archives of Pathology and Laboratory Medicine. In addition to numerous original articles, Dr. Khan has authored many book chapters and invited reviews and is currently editing a text book on surgical pathology of endocrine tumors.
Dr. Ashraf Khan’s clinical interest includes diagnostic surgical pathology of Breast and Endocrine system.
Dr. Ashraf Khan’s clinical interest includes diagnostic surgical pathology of Breast and Endocrine system.
Location
Maharastra, India
🇮🇳
About
Dr. Ashraf Khan’s clinical interest includes diagnostic surgical pathology of Breast and Endocrine system. Dr. Khan is actively involved in clinical translational research focused in the field of thyroid and breast cancer investigating biomarkers that help in the diagnosis and prediction of outcome in these tumors. Over the past decade Dr. Khan has published several papers on the role of cell cycle regulatory proteins, translation initiation factors and cell adhesion molecules in the diagnosis of thyroid follicular tumors and progression of thyroid cancer. Dr. Khan was a key contributor of one large multi-institution international study published in The Lancet on the role of galectin 3 and CD44 in the diagnosis of thyroid malignancy. Dr. Khan’s collaboration with the basic scientists in the department of cancer biology at UMass has resulted in multiple projects includingb4-integrin signature in basal-like breast cancer which was recently published and Sox-9 expression in breast cancer which is work in progress. In addition Dr. Khan is a PI on a Department of Defense Grant in collaboration with Dr. Leslie Shaw in department of cancer biology looking at the Insulin Receptor Substrate Proteins (IRS1 and IRS2) in breast cancer with special focus on potential role they may play in Herceptin resistance in HER-2 positive breast cancer. He is also currently involved in studying the micro RNA signature in breast cancer especially estrogen receptor positive node negative tumors with potential therapeutic implications. Dr. Khan is a member of the UMASS graduate school of biomedical sciences representing cancer biology.
Dr. Khan is the past President and Secretary of the Endocrine Pathology Society, a companion society of the US and Canadian Academy of Pathology. He is a reviewer for a number of pathology and endocrinology journals, serves on the editorial board of the journal Endocrine Pathology and is the Section Editor (Endocrine Pathology) of the Archives of Pathology and Laboratory Medicine. In addition to numerous original articles, Dr. Khan has authored many book chapters and invited reviews and is currently editing a text book on surgical pathology of endocrine tumors.
Languages
Address
Andrew Elkwood, MD, FACS, Physician
Dr. Elkwood is double board certified in general surgery and plastic surgery by the American Board of Plastic Surgery and the American Board of Surgery. He is a Fellow of the American College of Surgeons (FACS) and a member of the American Society of Plastic Surgeons as well as the American Society of Aesthetic Plastic Surgeons.
Matthew Kaufman, MD, FACS, Physician
Dr. Matthew R. Kaufman, M.D. is a Plastic & Reconstructive Surgeon board certified by both the American Board of Plastic Surgery & the American Board of Otolaryngology – Head and Neck Surgery. He is also a Fellow of the American College of Surgeons and is a member of The Rhinoplasty Society. Dr. Kaufman is co-Director of the Center for Treatment of Paralysis and Reconstructive Nerve Surgery at Jersey Shore University Medical Center, a Clinical Assistant Professor of Surgery at the David Geffen UCLA Medical Center in Los Angeles, California and an assistant professor in the Department of Plastic and Reconstructive Surgery at Seton Hall-Hackensack Meridian School of Medicine.
Dr. Sam Najmabadi
Sam Najmabadi, M.D., is board-certified in Obstetrics and Gynecology (OB/GYN) as well as board-certified in Reproductive Endocrinology and Infertility (RE/I). He is a past Assistant Clinical Professor in the Department of OB/GYN at the University of Southern California (USC) School of Medicine and currently is Adjunct Assistant Professor at Turo University of California College of Osteopathic Medicine.
Dr. José Luis Rivas Aguilar
Dr. José Luis Rivas Aguilar is certified in gynecology and obstetrics from the OBGYN Mexican Council. He also holds the certification for Biology of Human Reproduction from the OBGYN Mexican Council.
